Is radiotherapy effective as a bridging therapy for CAR T-cell therapy?

Zenodo (CERN European Organization for Nuclear Research) 2026 Open access

Read full text
Authors: Tripdatabase
DOI: 10.5281/zenodo.18785892
Cited by: 0

Abstract

Radiotherapy is an effective bridging therapy for CAR T-cell therapy in hematological malignancies, providing disease control and improved survival outcomes with manageable safety profiles.

Fields of Study & Subjects

CAR-T cell therapy research Radiopharmaceutical Chemistry and Applications Protein Degradation and Inhibitors

Publication details

Journal / source
Zenodo (CERN European Organization for Nuclear Research)
Publication date
26 February 2026
Language
EN